Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir Liquipatch versus acyclovir cream for recurrent herpes labialis
2008-005835-14Phase 3Terminated
- Sponsor
- Mipharm
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aciclovir in herpes labialis and herpes simplex (HSV) (2 arms), sponsored by Mipharm. Primary endpoint: Time to healing. Started Feb 2009; status: terminated.
02
Drugs
aciclovir
03
Conditions
herpes labialisherpes simplex (HSV)
Beyond the preview
Go deeper on 2008-005835-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005835-14.